|
A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis Clinical research trials and A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis. A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis clinical trial. Participants typically obtain the most effective healthcare available for their A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis  A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis
A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis
For Condition: HIV Infections,Candidiasis, esophageal
Status: Completed
Sponsor(s): Merck Research Laboratories ,
Synopsis: The purpose of this study is to see if it is safe to give L-743,872 to men with candidal esophagitis, an AIDS-related yeast infection in the esophagus.
Details: In this open-label study, patients receive intravenous L-743,872 every 24 hours at one of three dose levels for 14 days. Post-study safety evaluations continue for 4 weeks after the final dose. Pharmacokinetics and safety measurements are taken throughout the 6-week study.
Eligibility:
Study Type: Interventional, Treatment, Open Label, Pharmacokinetics Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Male
Protocol Entry Criteria: Inclusion Criteria You may be eligible for this study if you: - Are an 18- to 65-year-old man with candidal esophagitis.
Total Enrollment: 18
Location and Contact Information:
Gary Calandra
Rahway, New Jersey, 07065
United States
Additional Information:
Study ID Numbers: 267A; 007-00
Study Start Date:
Record last reviewed: June 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005921
Other Hiv Infections Studies:
1. Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success with Nelfinavir
2. Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
3. Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
4. The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients with AIDS Who Have Taken Zidovudine
5. Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
Related Studies:
Other HIV Infections Clinical Trials
Other New Jersey Clinical Trials
Other Rahway Clinical Trials
A Study of the Side Effects of L-743,872 in Men with Candidal Esophagitis
|
|
|
|
|
|
|
|
